These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11692169)

  • 1. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial.
    Service FJ; O'Brien PC
    Diabetologia; 2001 Oct; 44(10):1215-20. PubMed ID: 11692169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Goode K; Atkin SL
    Diabetologia; 2007 Dec; 50(12):2553-61. PubMed ID: 17882397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.
    Nathan DM; McGee P; Steffes MW; Lachin JM;
    Diabetes; 2014 Jan; 63(1):282-90. PubMed ID: 23990364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin].
    Jaffiol C; Jacques-Apostol D; Renard E; Millet P; Compeyre S; Lauton D; Picot MC; Bringer J
    Bull Acad Natl Med; 1996 Jan; 180(1):177-91; discussion 191-4. PubMed ID: 8696875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of glycemic variables on hemoglobin A1c.
    Service FJ; O'Brien PC
    Endocr Pract; 2007; 13(4):350-4. PubMed ID: 17669710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes.
    Schernthaner G; Wein W; Shnawa N; Bates PC; Birkett MA
    Diabet Med; 2004 Mar; 21(3):279-84. PubMed ID: 15008840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at diagnosis, glycaemic control and the development of retinopathy in a population-based cohort of Type 1 diabetic subjects in Canterbury, New Zealand.
    Florkowski CM; Scott RS; Coope PA; Graham PJ; Moir CL
    Diabetes Res Clin Pract; 2001 May; 52(2):125-31. PubMed ID: 11311967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
    Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?
    Hillman N; Herranz L; Grande C; Vaquero PM; Pallardo LF
    Diabet Med; 2004 May; 21(5):468-70. PubMed ID: 15089792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.
    Zhang L; Krzentowski G; Albert A; Lefebvre PJ
    Diabetes Care; 2001 Jul; 24(7):1275-9. PubMed ID: 11423515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.
    Kilpatrick ES; Rigby AS; Atkin SL
    Clin Chem; 2007 May; 53(5):897-901. PubMed ID: 17384010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
    Rohlfing CL; Wiedmeyer HM; Little RR; England JD; Tennill A; Goldstein DE
    Diabetes Care; 2002 Feb; 25(2):275-8. PubMed ID: 11815495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study.
    Guillausseau PJ; Massin P; Charles MA; Allaguy H; Güvenli Z; Virally M; Tielmans D; Assayag M; Warnet A; Lubetzki J
    Diabet Med; 1998 Feb; 15(2):151-5. PubMed ID: 9507917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.